Ignite Creation Date:
2025-12-25 @ 3:54 AM
Ignite Modification Date:
2026-01-28 @ 9:52 PM
Study NCT ID:
NCT01621802
Status:
COMPLETED
Last Update Posted:
2019-11-25
First Post:
2012-06-14
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Subjects Four to Six Years of Age
Sponsor:
Organization: